BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 14613290)

  • 1. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling.
    Li X; Wu J; Carter RH; Edberg JC; Su K; Cooper GS; Kimberly RP
    Arthritis Rheum; 2003 Nov; 48(11):3242-52. PubMed ID: 14613290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling.
    Kono H; Kyogoku C; Suzuki T; Tsuchiya N; Honda H; Yamamoto K; Tokunaga K; Honda Z
    Hum Mol Genet; 2005 Oct; 14(19):2881-92. PubMed ID: 16115811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility.
    Kyogoku C; Dijstelbloem HM; Tsuchiya N; Hatta Y; Kato H; Yamaguchi A; Fukazawa T; Jansen MD; Hashimoto H; van de Winkel JG; Kallenberg CG; Tokunaga K
    Arthritis Rheum; 2002 May; 46(5):1242-54. PubMed ID: 12115230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
    Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional variant of the inhibitory Fcgamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis.
    Radstake TR; Franke B; Wenink MH; Nabbe KC; Coenen MJ; Welsing P; Bonvini E; Koenig S; van den Berg WB; Barrera P; van Riel PL
    Arthritis Rheum; 2006 Dec; 54(12):3828-37. PubMed ID: 17133580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.
    Horton HM; Chu SY; Ortiz EC; Pong E; Cemerski S; Leung IW; Jacob N; Zalevsky J; Desjarlais JR; Stohl W; Szymkowski DE
    J Immunol; 2011 Apr; 186(7):4223-33. PubMed ID: 21357255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization.
    Veri MC; Gorlatov S; Li H; Burke S; Johnson S; Stavenhagen J; Stein KE; Bonvini E; Koenig S
    Immunology; 2007 Jul; 121(3):392-404. PubMed ID: 17386079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level signaling generated by FcgammaRIIB-B cell receptor co-ligation establishes a state of global B cell receptor nonresponsiveness.
    Preissler MT; Kaiser L; Drake JR; Gosselin EJ
    Immunol Invest; 2005; 34(1):53-70. PubMed ID: 15773572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences of a MAPK docking site on human FcgammaRIIb.
    Medgyesi D; Sárközi R; Koncz G; Arató K; Váradi G; Tóth GK; Sármay G
    Immunol Lett; 2004 Mar; 92(1-2):83-90. PubMed ID: 15081531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis reveals multiple distinct sites within Fc gamma receptor IIB that function in inhibitory signaling.
    Fong DC; Brauweiler A; Minskoff SA; Bruhns P; Tamir I; Mellman I; Daeron M; Cambier JC
    J Immunol; 2000 Oct; 165(8):4453-62. PubMed ID: 11035084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
    Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
    Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the autoimmune Fcgr2b NZW allele fails to be upregulated in germinal center B cells and is associated with increased IgG production.
    Rahman ZS; Niu H; Perry D; Wakeland E; Manser T; Morel L
    Genes Immun; 2007 Oct; 8(7):604-12. PubMed ID: 17713556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Through an ITIM-independent mechanism the FcγRIIB blocks B cell activation by disrupting the colocalized microclustering of the B cell receptor and CD19.
    Xu L; Li G; Wang J; Fan Y; Wan Z; Zhang S; Shaheen S; Li J; Wang L; Yue C; Zhao Y; Wang F; Brzostowski J; Chen YH; Zheng W; Liu W
    J Immunol; 2014 Jun; 192(11):5179-91. PubMed ID: 24790152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling.
    Kochi Y; Myouzen K; Yamada R; Suzuki A; Kurosaki T; Nakamura Y; Yamamoto K
    J Immunol; 2009 Nov; 183(9):5502-10. PubMed ID: 19843936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD72 polymorphisms associated with alternative splicing modify susceptibility to human systemic lupus erythematosus through epistatic interaction with FCGR2B.
    Hitomi Y; Tsuchiya N; Kawasaki A; Ohashi J; Suzuki T; Kyogoku C; Fukazawa T; Bejrachandra S; Siriboonrit U; Chandanayingyong D; Suthipinittharm P; Tsao BP; Hashimoto H; Honda Z; Tokunaga K
    Hum Mol Genet; 2004 Dec; 13(23):2907-17. PubMed ID: 15459183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic organization of classical human low-affinity Fcgamma receptor genes.
    Su K; Wu J; Edberg JC; McKenzie SE; Kimberly RP
    Genes Immun; 2002 Oct; 3 Suppl 1():S51-6. PubMed ID: 12215903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.
    Santiago-Raber ML; Amano H; Amano E; Baudino L; Otani M; Lin Q; Nimmerjahn F; Verbeek JS; Ravetch JV; Takasaki Y; Hirose S; Izui S
    Arthritis Rheum; 2009 Aug; 60(8):2408-17. PubMed ID: 19644866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis.
    Wijngaarden S; van de Winkel JG; Jacobs KM; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2004 Dec; 50(12):3878-87. PubMed ID: 15593228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary glycoprotein (BGPa, CD66a, CEACAM1) mediates inhibitory signals.
    Chen T; Zimmermann W; Parker J; Chen I; Maeda A; Bolland S
    J Leukoc Biol; 2001 Aug; 70(2):335-40. PubMed ID: 11493628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex family-based study in systemic lupus erythematosus: association between the R620W polymorphism of PTPN22 and the FcgammaRIIa (CD32A) R131 allele.
    Balada E; Villarreal-Tolchinsky J; Ordi-Ros J; Labrador M; Serrano-Acedo S; Martinez-Lostao L; Vilardell-Tarrés M
    Tissue Antigens; 2006 Nov; 68(5):432-8. PubMed ID: 17092257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.